| Larry Abensur |
Larry Abensur is the founder of All. Diag SAS (1993), Biosynex SA (2005), and Dectra Pharm SAS (1994). He is currently the Chairman at Laboratoire SBH SAS, Gie Lab Otc, Biosynex Swiss SA, Biosynex Premier SA, and Manager at ALA Financière SARL. He is also the President & Director at Chembio Diagnostics, Inc. (starting in 2023) and Director at Theradiag SA (starting in 2022). He has previously held positions as Chairman at Prodiag SAS and Magnien SAS, Managing Director at PBS Orgenics, Product Manager-Human Biosynthetic Insulin at Eli Lilly & Co., and Marketing Manager-France Region at The Upjohn Co. Mr. Abensur has an MBA from INSEAD and an undergraduate degree from École Nationale Supérieure de Chimie de Paris. |
